MedTrace Logo

Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic

NCT02818803 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-06-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of propolis on the treatment of oral candidiasis, more specifically denture stomatitis. Half of participants will receive a standardized-propolis (EPP-AF®) gel formulation while the other half will receive miconazole gel, both for oral use.

Conditions

  • Candidiasis, Oral
  • Stomatitis, Denture

Interventions

OTHER

Propolis

DRUG

Miconazole

Sponsors & Collaborators

  • Financiadora de Estudos e Projetos

    collaborator OTHER

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Erica N Lia, PhD · Faculdade de Medicina de Ribeirão Preto/USP

  • Gisela M Pina, DDS · Unievangelica Anapolis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02818803 on ClinicalTrials.gov